March 9, 2021

Jonathan Genzen, MD, PhD, ARUP Laboratories’ chief operations officer, explains how the Johnson & Johnson SARS-CoV-2 vaccine works, and how it differs from the Moderna and Pfizer-BioNTech vaccines.

March 2, 2021


A year after some of the first COVID-19 cases were detected in the United States, an expert close to both the lab and the clinical response to the pandemic reflects on some

March 1, 2021

By the end of January, approximately 22–28% of Salt Lake County residents either had been infected with SARS-CoV-2 or had been vaccinated against the virus, according to the Utah HERO Project.

February 26, 2021


Thanks to new intelligent tracking technology, ARUP clients now have access to a new digital tool to more accurately predict when COVID-19 test results will be available.

February 16, 2021

In 2020, medical professionals visited the ARUP Institute for Learning (IFL) education website in record number to complete their continuing education (CE).

February 10, 2021

Diagnostic laboratory testing remains important for detecting active COVID-19 infection in vaccinated, partially vaccinated, and unvaccinated individuals.

February 3, 2021

Point-of-care antigen testing with the Abbott BinaxNOW COVID-19 Ag Card is not as sensitive as standard NAATs for detecting SARS-CoV-2 in asymptomatic college students, according to a study.

January 26, 2021


ARUP Laboratories’ medical directors were involved in the publication of more than 115 peer-reviewed articles in academic journals in 2020.

January 19, 2021

ARUP Laboratories announced that it is sequencing variants of SARS-CoV-2 in specimens positive for COVID-19 to enable detection of the more contagious “United Kingdom (UK) variant” of the virus.

January 13, 2021

ARUP and University of Utah Health continue to research the safety and efficacy of COVID-19 convalescent plasma (CCP) in four multicenter randomized clinical trials.